Results

Opko Health Inc.

09/24/2021 | Press release | Distributed by Public on 09/24/2021 14:29

Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency